AI experimentation is accelerating across healthcare, but moving from individual pilots to a coordinated enterprise strategy introduces new challenges around investment, governance, risk, capacity, adoption, and value. This interactive roundtable will bring healthcare leaders together to share how they are prioritizing AI opportunities, establishing governance without slowing innovation, and managing AI initiatives as part of the broader enterprise portfolio. The discussion will focus on practical lessons for moving from scattered use cases to a sustainable enterprise AI portfolio that aligns investments to strategic priorities and delivers measurable business and clinical outcomes.